Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (7790)	5/12/2005 2:23:46 PM
From: Galirayo	Read Replies (1) \| Respond to of 23958

I may just be giving back some to the market Gods on GLW.

To: Sergio H who wrote (7790)	5/17/2005 8:52:41 AM
From: Galirayo	Respond to of 23958

Sergio .. Looks like ASTM .. was just waiting to be removed so it could mock us. MarketWatch Market Pulse: Aastrom shares get a lift from positive trial results Tuesday May 17, 8:27 am ET By Michael Baron NEW YORK (MarketWatch) -- Shares of Aastrom Biosciences jumped 11.7% to $2.30 in pre-market action. Volume of 141,759 made the issue the second most active stock on Instinet. The company early Tuesday reported positive results of a feasibility clinical trial of its Tissue Repair Cells for the treatment of severe long bone non-union fractures. Aastrom said the trial showed five of six patients receiving its TRC treatments showed bone regeneration at the fracture site as determined by radiographic imaging by six months. [ actually it's more like 19% ] :( finance.yahoo.com